ANI Pharmaceuticals

$29.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (+0.24%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell ANIP and other stocks, options, and ETFs commission-free!

About ANIP

ANI Pharmaceuticals, Inc., also called ANI Pharmaceuticals, is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN. The listed name for ANIP is ANI Pharmaceuticals, Inc.

CEO
Nikhil Lalwani
Employees
338
Headquarters
Baudette, Minnesota
Founded
1996
Market Cap
361.61M
Price-Earnings Ratio
Dividend Yield
Average Volume
72.00K
High Today
$29.51
Low Today
$28.50
Open Price
$29.07
Volume
28.99K
52 Week High
$68.19
52 Week Low
$23.55

Collections

ANIP Earnings

$0.00
$0.48
$0.96
$1.44
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 25, Pre-Market

You May Also Like